Source: Molecular Cancer Therapeuthics. Unidade: ICB
Assunto: MICROBIOLOGIA
ABNT
DINIZ, Mariana O. et al. Protection against HPV-16-associated tumors requires the activation of CD8+ effector memory T cells and the control of myeloid-derived suppressor cells. Molecular Cancer Therapeuthics, v. 15, n. 8, p. 1920-1930, 2016Tradução . . Disponível em: https://doi.org/10.1158/1535-7163.MCT-15-0742. Acesso em: 25 ago. 2024.APA
Diniz, M. O., Sales, N. S., Silva, J. R., & Ferreira, L. C. de S. (2016). Protection against HPV-16-associated tumors requires the activation of CD8+ effector memory T cells and the control of myeloid-derived suppressor cells. Molecular Cancer Therapeuthics, 15( 8), 1920-1930. doi:10.1158/1535-7163.MCT-15-0742NLM
Diniz MO, Sales NS, Silva JR, Ferreira LC de S. Protection against HPV-16-associated tumors requires the activation of CD8+ effector memory T cells and the control of myeloid-derived suppressor cells [Internet]. Molecular Cancer Therapeuthics. 2016 ; 15( 8): 1920-1930.[citado 2024 ago. 25 ] Available from: https://doi.org/10.1158/1535-7163.MCT-15-0742Vancouver
Diniz MO, Sales NS, Silva JR, Ferreira LC de S. Protection against HPV-16-associated tumors requires the activation of CD8+ effector memory T cells and the control of myeloid-derived suppressor cells [Internet]. Molecular Cancer Therapeuthics. 2016 ; 15( 8): 1920-1930.[citado 2024 ago. 25 ] Available from: https://doi.org/10.1158/1535-7163.MCT-15-0742